Skip to main content
Premium Trial:

Request an Annual Quote

Roche Inks Reagents Distribution Deal with Sigma-Aldrich

NEW YORK (GenomeWeb) – Sigma-Aldrich today announced it has signed an agreement with Roche to become the exclusive global distributor of Roche's Biochemical Reagents products portfolio.

Under the terms of the agreement, Sigma-Aldrich will employ its sales, marketing, and e-commerce expertise, and relationships with the scientific community to present and distribute the Roche reagents. The Roche products include kits and enzymes for cellular analysis, proteomics, and conventional PCR applications.

Financial details of the agreement were not disclosed.

"The addition of these life science tools supports our strategy to augment our portfolio with products that accelerate customer scientific research programs," Eric Green, president of Sigma-Aldrich Research, said in a statement.

The agreement will allow Roche to devote more resources to its primary areas of focus, added Paul Brown, head of Roche Molecular Diagnostics.

Sigma-Aldrich will take over distribution of the Roche portfolio sometime this year, the firm said in a statement. Until then, the products will continue to be available through existing Roche channels.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.